Industry Insights

31. The Strategic Case For RTSM in Phase 1 Trials 12/5/2025

    Phase 1 trials demand precision and speed. RTSM delivers real-time control over enrollment, dosing, and supply, reducing risk and enabling adaptive strategies that keep timelines on track.

32. Demystifying AI In Clinical Trials 12/5/2025

    AI is revolutionizing clinical trials by improving efficiency and data quality, but success depends on strategy and oversight. Explore practical ways to integrate AI responsibly.

33. Navigating The Challenges Of Cell Therapy Clinical Trials 12/5/2025

    IN8bio CEO William Ho shares how they overcame operational challenges unique to cell therapy research, including how to carefully conduct site expansion and onboard new sites without disrupting study timelines.

34. Why Data Integrity Still Matters — Even As Clinical Trials Evolve 12/4/2025

    Data integrity remains essential for compliance and patient safety. Learn strategies to maintain accuracy and reliability as clinical research evolves toward more connected, technology-driven models.

35. Clinical Trial Governance A Strategic Look At KPIs From An RTSM Perspective 12/4/2025

    Learn how data-driven metrics improve oversight, mitigate risk, and accelerate execution while safeguarding supply continuity and patient safety.

36. Beyond the Acronyms: What Today's Trials Really Need From RTSM 12/4/2025

    Consider how resin selection, process optimization, and system qualification create scalable workflows that meet evolving regulatory and operational demands in modern biomanufacturing.

37. Finding The Solution(s) That Meet The Needs Of Patients, Sites, And Sponsors 12/4/2025

    Poor enrollment and retention often stem from patient burden and limited site access. Learn how leveraging diverse site networks and remote support can transform the clinical trial experience.

38. Why Clinical Trial Demographics Don't Match Real-World Populations 12/4/2025

    Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.

39. How Mobile Clinics Advance Diversity In Clinical Research 12/4/2025

    Mobile clinics reduce participation barriers, enable more inclusive trials, deliver representative data, speed timelines, and advance equity in research.

40. Virtual Clinical Trials For Ophthalmic Measures 12/4/2025

    Remote ophthalmic assessments such as BCVA, OCT, and IOP expand trial access and efficiency, preserving data quality while reducing site burden and boosting patient engagement.